Geron Corporation
Clinical trials sponsored by Geron Corporation, explained in plain language.
-
New hope for Tough-to-Treat bone marrow cancer?
Disease control OngoingThis study tests a new drug, imetelstat, against the best current treatments for people with a serious bone marrow cancer called myelofibrosis. Participants have a high-risk form of the disease that no longer responds to standard therapy. The goal is to see if imetelstat helps pe…
Phase: PHASE3 • Sponsor: Geron Corporation • Aim: Disease control
Last updated May 17, 2026 09:09 UTC
-
New hope for MDS patients: drug aims to break transfusion dependency
Disease control OngoingThis study tests an experimental drug called imetelstat in adults with a type of bone marrow cancer (MDS) who currently need regular blood transfusions and have stopped responding to standard treatments. The main goal is to see if the drug can help patients go 8 weeks or longer w…
Phase: PHASE2, PHASE3 • Sponsor: Geron Corporation • Aim: Disease control
Last updated May 13, 2026 16:00 UTC